title: Circulating fibroblast growth factor 23 increases following intermittent parathyroid hormone (1-34) in postmenopausal osteoporosis: association with biomarker of bone formation.
authors.forename: James
authors.initials: J
authors.lastname: Mahon
authors.forename: Miriam
authors.initials: M
authors.lastname: Casey
mesh_terms: D054316:Biomarkers, Pharmacological / Q000032:analysis / Q000097:blood*; D004164:Diphosphonates / Q000627:therapeutic use; D004334:Drug Administration Schedule; D005260:Female; D000089703:Fibroblast Growth Factor-23; D005346:Fibroblast Growth Factors / Q000097:blood / Q000502:physiology*; D006801:Humans; D055118:Medication Adherence; D010012:Osteogenesis / Q000187:drug effects* / Q000502:physiology; D015663:Osteoporosis, Postmenopausal / Q000097:blood* / Q000188:drug therapy*; D010281:Parathyroid Hormone / Q000008:administration & dosage*
chemical_list: D054316:Biomarkers, Pharmacological; D004164:Diphosphonates; D010281:Parathyroid Hormone; D005346:Fibroblast Growth Factors; D000089703:Fibroblast Growth Factor-23